Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Movement disorders
How do you decide between Vyalev and Onapgo for patients who would benefit from continuous dopaminergic stimulation?
Related previous discussion on
theMednet on Vyalev
.
Answer from: at Academic Institution
Either is fine.
Sign In
or
Register
to read more
30087
Related Questions
How do you approach a patient who develops a rest tremor after chemotherapy?
How do you decide between the different oral longer acting levodopa medications?
Which essential tremor phenotypes benefit most from wearable peripheral nerve stimulator devices?
How do you treat nocturnal leg cramps?
How do you manage levodopa in a patient with Parkinson's and RLS with augmentation?
Have you had success with the Cala Trio device for essential tremor?
What is your approach to bothersome dyskinesias in Parkinson disease patients?
Do you ever delay starting levodopa in patients with Parkinson's disease?
What is your approach to Tardive Dyskinesia when VMAT2 inhibitors are ineffective or unaffordable?
How do you manage and adjust Parkinson’s medication if a patient has worsening orthostatic hypotension while being treated with carbidopa/levodopa?